NCT00853892View on ClinicalTrials.gov

Fasting Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Healthy
Interventions
DRUG

Controlled-Release Oxycodone Hydrochloride 40 mg tablet

Controlled-Release Oxycodone Hydrochloride 40 mg, single dose fasting

DRUG

OxyContin® 40 mg tablet

OxyContin® 40 mg tablet, single dose fasting

Trial Locations (1)

65801

Bio-Kinetic Clinical Applications, Springfield

Sponsors

Lead Sponsor

Mallinckrodt
All Listed Sponsors
lead

Mallinckrodt

INDUSTRY

NCT00853892 - Fasting Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets | Biotech Hunter | Biotech Hunter